Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerda de Vries

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Methods (San Diego, Calif.)|January 25, 2003
Using FRAP and mathematical modeling to determine the in vivo kinetics of nuclear proteinsGustavo Carrero, Darin McDonald, Ellen Crawford, et al.
Biophysical Journal|March 16, 2011
Analysis of molecular diffusion by first-passage time variance identifies the size of confinement zonesVishaal Rajani, Gustavo Carrero, David E Golan, et al.
Diabetes|September 30, 2003
Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes?Michael J Riedel, Parveen Boora, Diana Steckley, et al.
Cancer Treatment Reviews|June 29, 2020
Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunitiesGerda de Vries, Ximena Rosas-Plaza, Marcel A T M van Vugt, et al.
Molecular Cancer Therapeutics|November 21, 2019
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin TreatmentXimena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, et al.
Scientific Reports|November 4, 2020
Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategiesGerda de Vries, Ximena Rosas-Plaza, Gert Jan Meersma, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Methods (San Diego, Calif.)|January 25, 2003
Using FRAP and mathematical modeling to determine the in vivo kinetics of nuclear proteinsGustavo Carrero, Darin McDonald, Ellen Crawford, et al.
Biophysical Journal|March 16, 2011
Analysis of molecular diffusion by first-passage time variance identifies the size of confinement zonesVishaal Rajani, Gustavo Carrero, David E Golan, et al.
Diabetes|September 30, 2003
Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes?Michael J Riedel, Parveen Boora, Diana Steckley, et al.
Cancer Treatment Reviews|June 29, 2020
Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunitiesGerda de Vries, Ximena Rosas-Plaza, Marcel A T M van Vugt, et al.
Molecular Cancer Therapeutics|November 21, 2019
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin TreatmentXimena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, et al.
Scientific Reports|November 4, 2020
Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategiesGerda de Vries, Ximena Rosas-Plaza, Gert Jan Meersma, et al.
Pageof 2